المؤلفون: Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic., Sher T; Division of Hematology-Oncology, Mayo Clinic., Azzouqa AG; Division of Hematology-Oncology, Mayo Clinic., Meghji Z; Division of Hematology-Oncology, Mayo Clinic., Jain T; Division of Hematology-Oncology, Mayo Clinic., Jani P; Division of Hematology-Oncology, Mayo Clinic., Ahmed S; Division of Hematology-Oncology, Mayo Clinic., Diehl N; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, Florida., Roy V; Division of Hematology-Oncology, Mayo Clinic., Shah V; Department of Pharmacology, Mayo Clinic, Scottsdale, Arizona, USA., Hodge D; Department of Health Sciences and Research, Mayo Clinic, Jacksonville, Florida., Ailawadhi M; Division of Hematology-Oncology, Mayo Clinic., Alegria VR; Division of Hematology-Oncology, Mayo Clinic., Paulus A; Division of Hematology-Oncology, Mayo Clinic., Chanan-Khan A; Division of Hematology-Oncology, Mayo Clinic., Fonseca R; Division of Hematology-Oncology, Mayo Clinic.

المصدر: Anti-cancer drugs [Anticancer Drugs] 2019 Sep; Vol. 30 (8), pp. 859-865.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Drug Resistance, Neoplasm/*drug effects , Drug-Related Side Effects and Adverse Reactions/*epidemiology , Multiple Myeloma/*drug therapy , Neoplasm Recurrence, Local/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Drug Resistance, Neoplasm/immunology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Multiple Myeloma/immunology ; Multiple Myeloma/pathology ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Salvage Therapy ; Survival Rate ; United States/epidemiology